Cantor Fitzgerald sets Vaxcyte target at $120 and keeps Alphabet at $420
Cantor Fitzgerald set a $120-per-share target for Vaxcyte and maintained its $420 target for Alphabet, according to ratings data from Benzinga.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Cantor Fitzgerald set a price target of $120 per share for Vaxcyte. The information appears in Benzinga’s analyst-ratings materials, cited by Dow Jones Newswires.
For Alphabet, Cantor Fitzgerald maintained its $420-per-share target. Benzinga published the information in the company’s analyst-ratings section.
why it matters
Changes to analyst targets are monitored by markets as indicators of a brokerage’s view on individual companies. This update concerns Vaxcyte and Alphabet shares.
instruments
sources
- Vaxcyte Price Target Announced at $120.00/Share by Cantor Fitzgerald — Dow Jones Newswires, 12 October 2026 at 11:08 UTC
- Alphabet Price Target Maintained With a $420.00/Share by Cantor Fitzgerald — Dow Jones Newswires, 12 October 2026 at 11:17 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗